Join BHOF Chief Medical Officer, Andrea Singer, MD and Cate Lockhart, PharmD, PhD, Executive Director of the Biologics and Biosimilars Collective Intelligence Consortium for an informative webinar on Monday, July 8th at 3:00PM ET about osteoporosis medication and treatment options. You will learn about weighing the associated benefits and risks of medications and gain insight into speaking with your healthcare practitioner about treatment planning and osteoporosis management. The differences between biologics and biosimilars will also be discussed.
Register here: https://us06web.zoom.us/webinar/register/WN_7qlkJjjAScicsKNQb8ylqw
We would like to extend a special thank you to Sandoz for sponsoring this webinar.
To stay updated with BHOF events and receive our quarterly newsletter, please sign up here.
If you have any questions, please email info@bonehealthandosteoporosis.org.